Caribou Biosciences, Inc. (CRBU)
Nasdaq: CRBU · Biological Products, (No Diagnostic Substances) · Berkeley, CA · filing with the SEC since 2014
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 5, 2026 | Mar 10, 2025 | Mar 11, 2024 | Mar 9, 2023 | Mar 21, 2022 | · | · |
| Revenue | 11,159 | 9,994 | 34,477 | 13,851 | 9,598 | 12,361 | 5,788 |
| Research and development | 109,439 | 130,153 | 112,075 | 82,230 | 52,255 | 34,425 | 23,635 |
| General and administrative | 37,914 | 46,457 | 38,461 | 38,020 | 24,322 | 14,060 | 16,458 |
| Total operating expenses | 159,503 | 176,610 | 150,536 | 120,250 | 76,577 | 48,485 | 40,093 |
| Operating income | -148,344 | -166,616 | -116,059 | -106,399 | -66,979 | -36,124 | -34,305 |
| Interest expense | · | · | · | · | 8 | 20 | 4 |
| Interest and investment income | · | · | · | · | 148 | 236 | 1,047 |
| Total non-operating income (expense) | -331 | 17,502 | 14,182 | 7,048 | 377 | -3 | 3,337 |
| Income before income taxes | -148,675 | -149,114 | -101,877 | -99,351 | -66,602 | -36,127 | -30,968 |
| Income tax expense | -550 | -9 | 193 | 70 | 321 | -1,819 | -7,537 |
| Net income including non-controlling interests | -148,125 | -149,105 | -102,070 | -99,421 | -66,923 | -34,308 | -23,431 |
| Net income | -148,125 | -149,105 | -102,070 | -99,421 | -66,923 | -34,308 | -23,431 |
| Earnings per share, basic | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 | · | · |
| Earnings per share, diluted | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -2.11 | -4.01 | -2.80 |
| Weighted average shares, basic | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | · |
| Weighted average shares, diluted | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 31,663,243 | 8,546,741 | 8,374,674 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted